For instance, in response to a query about a lung adenocarcinoma patient with ERBB2 mutations showing recurrence after treatment with cisplatin and pemetrexed, the standard GPT-4 model suggested multiple therapies, including trastuzumab, afatinib, docetaxel, and pembrolizumab, alongside additional commentary on clinical trials, further genomic profiling, and palliative care. Here, ERBB2 is linked to lung adenocarcinoma.